| Item Type | Name |
|
Concept
|
Blood Pressure Monitoring, Ambulatory
|
|
Academic Article
|
Roundtable discussion: problems in the management of hypertension.
|
|
Academic Article
|
Comparison of telmisartan vs. valsartan in the treatment of mild to moderate hypertension using ambulatory blood pressure monitoring.
|
|
Academic Article
|
Assessing blood pressure control in dialysis patients: finally a step forward.
|
|
Academic Article
|
Comparative efficacy of two different beta-blockers on 24-hour blood pressure control.
|
|
Academic Article
|
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.
|
|
Academic Article
|
Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients.
|
|
Academic Article
|
Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial.
|
|
Academic Article
|
24-hour ambulatory blood pressure in the ACCOMPLISH trial.
|
|
Academic Article
|
Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.
|
|
Academic Article
|
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.
|
|
Academic Article
|
Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoring.
|
|
Academic Article
|
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial.
|
|
Academic Article
|
Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.
|
|
Academic Article
|
Can ambulatory blood pressure serve as a biomarker for presence of chronic kidney disease?
|
|
Academic Article
|
Hypertension goals in advanced-stage kidney disease.
|
|
Academic Article
|
Hypertension in 2011: New insights--from risk factors to treatment implications.
|
|
Academic Article
|
An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements.
|
|
Academic Article
|
Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
|
|
Academic Article
|
Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics.
|
|
Academic Article
|
Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
|
|
Academic Article
|
Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting.
|
|
Academic Article
|
Pediatrics: Masked hypertension: a risk factor in children with CKD.
|
|
Academic Article
|
Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
|
|
Academic Article
|
Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control.
|
|
Academic Article
|
The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure.
|
|
Academic Article
|
Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective.
|
|
Academic Article
|
Role of ambulatory blood pressure monitoring in hypertension and diabetes.
|
|
Academic Article
|
A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.
|
|
Academic Article
|
Recognition and management of masked hypertension: a review and novel approach.
|
|
Academic Article
|
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
|
|
Academic Article
|
Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly.
|
|
Academic Article
|
Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension.
|
|
Academic Article
|
Reply: A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3.
|
|
Academic Article
|
Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease.
|
|
Academic Article
|
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
|
|
Academic Article
|
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial.
|
|
Academic Article
|
Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension.
|
|
Academic Article
|
Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
|
|
Academic Article
|
Hydrochlorothiazide as the Diuretic of Choice for Hypertension: Time to Kick the Habit.
|
|
Academic Article
|
Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African-American patients with hypertension.
|
|
Academic Article
|
Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment.
|
|
Academic Article
|
Ambulatory Blood Pressure Monitoring.
|
|
Academic Article
|
The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.
|
|
Academic Article
|
High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3.
|
|
Academic Article
|
Has the Sun Set on Nighttime Dosing in Uncomplicated Hypertension?
|
|
Academic Article
|
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol.
|
|
Academic Article
|
Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis.
|
|
Academic Article
|
Improved Sleep Quality Improves Blood Pressure Control among Patients with Chronic Kidney Disease: A Pilot Study.
|
|
Academic Article
|
Time in Therapeutic Range: Redefining "Optimal" Blood Pressure Control.
|
|
Academic Article
|
Approach to Resistant Hypertension from Cardiology and Nephrology Standpoints: Tailoring Therapy.
|
|
Academic Article
|
Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification: 3-Year Results From the CALM-FIM Study.
|
|
Academic Article
|
Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension.
|
|
Academic Article
|
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes.
|
|
Academic Article
|
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
|
|
Academic Article
|
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.
|